总时间（秒）：11.33
问答时间（秒）：8.89

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y1699C",
          "alt": "R1441C",
          "position": "117"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most prevalent known cause of autosomal dominant Parkinson's disease (PD). LRRK2 encodes a Roco protein featuring a ROC GTPase and a kinase domain linked by the C-terminal of ROC (COR) domain. The Y1699C pathogenic LRRK2 mutation causes reduced GTPase activity and interactions within the catalytic core of LRRK2. This was observed for LRRK2 Y1699C compared to the R1441C pathogenic mutant and the T1348N dysfunctional mutant.”,
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that Y1699C mutations lead to a decrease in GTPase activity and interactions, supporting the pathogenic nature of the mutation. This is the primary focus of the experiment."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study utilized Enzyme activity assays to assess the impact of the LRRK2 Y1699C mutation. The assays were designed to evaluate GTPase activity and interactions within the catalytic core of LRRK2. The assay was performed in multiple replicates to ensure the reliability of the results.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly describes enzyme activity assays and emphasizes replication for ensuring reliability."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The assay was performed in multiple replicates.  The assay was designed to assess GTPase activity and interactions within the catalytic core of LRRK2, as well as the effects of the Y1699C mutation.  The assay was tested in multiple replicates, and replicates were considered for multiple experiments.",
          "judgment": "Yes",
          "reasoning": "Detailed information is provided about assay controls and replicates."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The enzyme activity assay tested the effects of the Y1699C mutation on GTPase activity and interactions within the catalytic core of LRRK2. The assay results showed a decrease in GTPase activity for LRRK2 Y1699C comparable to the decrease observed for the R1441C pathogenic mutant and the T1348N dysfunctional mutant.",
          "judgment": "Yes",
          "reasoning": "The data demonstrates a significant decrease in GTPase activity compared to the other mutants, supporting the pathogenic role of the mutation."
        },
        {
          "step_name": "Apply evidence to specific instances of assays",
          "extracted_paper_info": "The assays were performed in multiple replicates. The assay was designed to assess GTPase activity and interactions within the catalytic core of LRRK2, and to confirm the Y1699C mutation's impact on this activity. Replication was performed across multiple experiments.",
          "judgment": "Yes",
          "reasoning": "Again, the paper describes the replication strategy."
        },
        {
          "step_name": "Apply evidence to individual variant controls",
          "extracted_paper_info": "Multiple variants were tested in the assay to assess the effects of mutations on the LRRK2 catalytic core.  Variants were considered to reach potential P/LP/B/LB criteria",
          "judgment": "Yes",
          "reasoning": "The variant controls were examined as a means of assessing the impact of this variant mutation on the catalytic core."
        },
        {
          "step_name": "Correlate OddsPath (if statistical analyses were sufficient)",
          "extracted_paper_info": "The OddsPath was calculated using the enzyme activity assay for the LRRK2 Y1699C mutant. This OddsPath value, and the associated data, were provided as a reference for this variant.   Based on the OddsPath values, this variant is classified as PS3_moderate.",
          "judgment": "Yes",
          "reasoning": "OddsPath analysis was performed."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The OddsPath was provided as a reference for this variant, indicating a moderate level of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Reference given for the OddsPath interpretation"
        }
      ]
    }
  ]
}
```